PRNP and neurodegenerative disease: By providing first evidence for the involvement of vesicular PrP in extracellular EV motion, our study points at PrP and its neuronal interactor(s) as potential targets to limit diffusion of EV‐associated toxic amyloid proteins in patients affected by neurodegenerative diseases.